Monique Galitzky
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK).
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: July 17, 2025
A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 27, 2020
Broad white matter impairment in multiple system atrophy.
Journal: Human brain mapping
Published: August 02, 2019
A totally data-driven whole-brain multimodal pipeline for the discrimination of Parkinson's disease, multiple system atrophy and healthy control.
Journal: NeuroImage. Clinical
Published: January 21, 2019
Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson's disease.
Journal: Journal of neural transmission (Vienna, Austria : 1996)
Published: January 02, 2019
Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
Journal: Parkinsonism & related disorders
Published: December 03, 2018
Naftazone in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial.
Journal: Parkinsonism & related disorders
Published: July 11, 2018
MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: November 16, 2017
Apelin administration improves insulin sensitivity in overweight men during hyperinsulinaemic-euglycaemic clamp.
Journal: Diabetes, obesity & metabolism
Published: April 17, 2017
Parkinson's patients can rely on perspective cues to perceive 3D space.
Journal: Brain research
Published: January 06, 2017
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.
Journal: Neurology
Published: December 28, 2013
Simvastatin decreases levodopa-induced dyskinesia in monkeys, but not in a randomized, placebo-controlled, multiple cross-over ("n-of-1") exploratory trial of simvastatin against levodopa-induced dyskinesia in Parkinson's disease patients.
Journal: Parkinsonism & related disorders
Published: October 10, 2012
Last Updated: 09/26/2026